Find people 

Mr Jamie Horder  BA DPhil (forthcoming)
Postdoctoral Researcher

staff photo
emailcontact this person

Institute of Psychiatry
Box  P050
De Crespigny Park
United Kingdom, SE5 8AF

location 6th Floor
Main Wing
departmentsForensic and Neurodevelopmental Science


My DPhil research at Oxford focussed on the pharmacology of clinical depression using fMRI and cognitive testing.

My current work aims at understanding the neurobiology of autism using Magnetic Resonance Spectroscopy, and other methods, to investigate GABA and glutamate function in the brain.

I am also interested in antidepressants and the difficulties in evaluating and interpreting the evidence base in clinical trials in psychiatry, see Horder et al 2010.

Finally, I’ve long been involved in science communication and have written articles for The Guardian and appeared on BBC Radio 4, amongst others.

I am currently organising a series of lectures on autism to be run at the Institute of Psychiatry, the King’s Conversations on Autism. Please contact me for more details


1. Arnone D, Horder J, Cowen PJ, Harmer CJ. Early effects of mirtazapine on emotional processing. Psychopharmacology, 2009. 203(4): p. 685-91. DOI 10.1007/s00213-008-1410-6

2. Horder J, Cowen PJ, Di Simplicio M, Browning M, Harmer CJ. Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteers. Psychopharmacology, 2009. 205(1): p. 85-91. DOI 10.1007/s00213-009-1517-4

3. Horder, J, et al., Reduced neural response to reward following 7 days treatment with the cannabinoid CB1 antagonist rimonabant in healthy volunteers. Int J Neuropsychopharmacol 2010 (EPub Ahead of Print) DOI 10.1017/S1461145710000453

4. Horder J, Mathews P, Waldmann R. Placebo, Prozac and PLoS: Significant lessons for Psychopharmacology. Journal of Psychopharmacology 2010 (EPub Ahead of Print) DOI 10.1177/0269881110372544

5. Horder J Why do cannabinoid (CB1) antagonists cause depression? (under review J Psychopharmacology)

6. Horder J, Browning M, DiSimplicio M, Cowen PJ, Harmer CJ. Effects Of 7 Days Treatment With Cannabinoid Type 1 Antagonist, Rimonabant, On Emotional Processing (Accepted for Publication J Psychopharmacology)

last updated: Friday, January 28, 2011